Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 15401-15450 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT03975491
The Exercise And Colorectal Cancer Treatment Trial
NA
Active, not recruiting
60 participants
Started: Aug 1, 2019 · Completed: Jan 1, 2026
2 conditions
2 sponsors
1 location
NCT03107884
Role of Metformin on Muscle Health of Older Adults
EARLY_PHASE1
Active, not recruiting
64 participants
Started: Aug 1, 2019 · Completed: Nov 1, 2025
2 conditions
1 sponsor
1 location
NCT04006782
Narrow Dental Implants in Multiple Fixed Prosthesis: A Controlled Clinical Trial
NA
Active, not recruiting
48 participants
Started: Aug 1, 2019 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT04282317
Magnetic Resonance Imaging of the Brain and Stomach in Healthy Volunteers and Gastroparesis
NA
Active, not recruiting
31 participants
Started: Aug 1, 2019 · Completed: Dec 31, 2026
1 condition
3 sponsors
1 location
NCT07027137
The Influence of Local Antibiotic Therapy on the Outcomes Following Periodontal Regeneration Procedures.
NA
Active, not recruiting
40 participants
Started: Aug 1, 2019 · Completed: Dec 30, 2025
2 conditions
1 sponsor
1 location
NCT03681262
Comparing Long-term Effectiveness of High Frequency and Burst Spinal Cord Stimulation
NA
Active, not recruiting
7 participants
Started: Aug 1, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT03517137
Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study
PHASE2
Active, not recruiting
150 participants
Started: Aug 1, 2019 · Completed: Nov 16, 2026
1 condition
1 sponsor
16 locations
NCT03850847
Understanding Decision Making in the Intensive Care Unit: a National Study
N/A
Active, not recruiting
292 participants
Started: Aug 1, 2019 · Completed: Aug 31, 2025
1 condition
3 sponsors
9 locations
NCT04056390
Ablation STrategies for Repeat PrOcedures in Patients With Atrial Fibrillation Recurrences
NA
Active, not recruiting
256 participants
Started: Aug 1, 2019 · Completed: Feb 15, 2025
1 condition
3 sponsors
7 locations
NCT03867617
Cell Therapy for Immunomodulation in Kidney Transplantation
PHASE1/PHASE2
Active, not recruiting
12 participants
Started: Aug 1, 2019 · Completed: Jun 30, 2028
1 condition
2 sponsors
1 location
NCT03913715
Ostomy Rural Telehealth Training Cancer Survivors
NA
Active, not recruiting
204 participants
Started: Aug 1, 2019 · Completed: Oct 31, 2026
3 conditions
2 sponsors
10 locations
NCT04068844
Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction
NA
Active, not recruiting
93 participants
Started: Aug 1, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03284866
HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV
PHASE3
Active, not recruiting
536 participants
Started: Jul 31, 2019 · Completed: Mar 15, 2027
3 conditions
7 sponsors
6 locations
NCT04054557
Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence
NA
Active, not recruiting
305 participants
Started: Jul 31, 2019 · Completed: Dec 31, 2025
11 conditions
1 sponsor
5 locations
NCT04042753
Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors
PHASE2
Active, not recruiting
9 participants
Started: Jul 31, 2019 · Completed: Jul 31, 2026
4 conditions
1 sponsor
8 locations
NCT04133493
Omega3 Wound Fish Skin Graft in the Treatment of DFUs
NA
Active, not recruiting
100 participants
Started: Jul 31, 2019 · Completed: Jan 30, 2023
1 condition
1 sponsor
5 locations
NCT03617198
CD4 CAR+ ZFN-modified T Cells in HIV Therapy
PHASE1
Active, not recruiting
12 participants
Started: Jul 31, 2019 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT04063878
A Clinical Study on Acuris™ - Conometric Concept for Single Tooth Restoration
NA
Active, not recruiting
160 participants
Started: Jul 30, 2019 · Completed: Jun 30, 2027
1 condition
1 sponsor
9 locations
NCT03978689
A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma
PHASE1
Active, not recruiting
85 participants
Started: Jul 30, 2019 · Completed: Jan 31, 2026
3 conditions
2 sponsors
17 locations
NCT03606577
An Intensive Program With Quadruplet Induction and Consolidation Plus Tandem Autologous Stem Cell Transplantation in Newly Diagnosed High Risk Multiple Myeloma Patients
PHASE2
Active, not recruiting
50 participants
Started: Jul 30, 2019 · Completed: Nov 8, 2027
1 condition
1 sponsor
12 locations
NCT03736226
A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China
N/A
Active, not recruiting
2,000 participants
Started: Jul 30, 2019 · Completed: Mar 31, 2028
1 condition
1 sponsor
1 location
NCT03932643
ONC-201 Maintenance Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome After Stem Cell Transplant
PHASE1
Active, not recruiting
20 participants
Started: Jul 30, 2019 · Completed: Aug 31, 2027
2 conditions
1 sponsor
1 location
NCT03950609
Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors
PHASE2
Active, not recruiting
36 participants
Started: Jul 30, 2019 · Completed: Mar 30, 2026
5 conditions
2 sponsors
1 location
NCT03968653
Study of Oral Debio 0123 in Combination With Carboplatin in Participants With Advanced Solid Tumors
PHASE1
Active, not recruiting
76 participants
Started: Jul 30, 2019 · Completed: Nov 30, 2027
1 condition
1 sponsor
8 locations
NCT03797196
RCT Comparing Immunosuppressive Regimens in Elderly Renal Transplant Recipients
PHASE4
Active, not recruiting
374 participants
Started: Jul 29, 2019 · Completed: Dec 31, 2026
3 conditions
8 sponsors
7 locations
NCT03984097
A Study to Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM)
PHASE1
Active, not recruiting
50 participants
Started: Jul 29, 2019 · Completed: Mar 31, 2026
1 condition
1 sponsor
9 locations
NCT04023526
A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy
PHASE2
Active, not recruiting
103 participants
Started: Jul 29, 2019 · Completed: May 15, 2026
1 condition
3 sponsors
56 locations
NCT03937843
Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma
PHASE2
Active, not recruiting
135 participants
Started: Jul 29, 2019 · Completed: Dec 31, 2046
2 conditions
2 sponsors
19 locations
NCT03861273
A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B
PHASE3
Active, not recruiting
51 participants
Started: Jul 29, 2019 · Completed: Feb 25, 2031
1 condition
1 sponsor
60 locations
NCT03927027
Axillary Reverse Mapping in Preventing Lymphedema in Patients with Breast Cancer Undergoing Axillary Lymph Node Dissection
PHASE3
Active, not recruiting
534 participants
Started: Jul 29, 2019 · Completed: Jan 31, 2027
3 conditions
2 sponsors
96 locations
NCT03834493
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
PHASE3
Active, not recruiting
1,244 participants
Started: Jul 28, 2019 · Completed: May 29, 2026
1 condition
1 sponsor
259 locations
NCT03811002
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
PHASE3
Active, not recruiting
544 participants
Started: Jul 26, 2019 · Completed: Feb 21, 2026
4 conditions
2 sponsors
543 locations
NCT03860961
Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy
NA
Active, not recruiting
546 participants
Started: Jul 26, 2019 · Completed: Nov 14, 2026
1 condition
2 sponsors
79 locations
NCT03814746
Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients
PHASE3
Active, not recruiting
255 participants
Started: Jul 26, 2019 · Completed: Dec 14, 2026
1 condition
1 sponsor
59 locations
NCT06751875
PRASED - Preventing Relapse After Successful Electroconvulsive Therapy for Depression
NA
Active, not recruiting
109 participants
Started: Jul 26, 2019 · Completed: Apr 30, 2025
1 condition
1 sponsor
1 location
NCT04036305
Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers
N/A
Active, not recruiting
230 participants
Started: Jul 26, 2019 · Completed: Dec 31, 2029
2 conditions
2 sponsors
1 location
NCT04041063
Rehabilitation and Cortical Remodeling After Surgical Intervention for Spinal Cord Injury
PHASE2
Active, not recruiting
6 participants
Started: Jul 26, 2019 · Completed: Dec 31, 2026
3 conditions
2 sponsors
1 location
NCT03968822
Intralipid® 20% for Reversal of Local Anesthetics
PHASE4
Active, not recruiting
18 participants
Started: Jul 26, 2019 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
NCT03949283
Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer
PHASE3
Active, not recruiting
150 participants
Started: Jul 26, 2019 · Completed: Dec 30, 2024
2 conditions
1 sponsor
8 locations
NCT03909334
Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
PHASE2
Active, not recruiting
160 participants
Started: Jul 25, 2019 · Completed: Jan 31, 2026
4 conditions
3 sponsors
12 locations
NCT03737994
Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer
PHASE2
Active, not recruiting
10 participants
Started: Jul 25, 2019 · Completed: Dec 2, 2025
4 conditions
2 sponsors
491 locations
NCT04039750
Use of Antibiotic Irrigation to Decrease Wound Infections in Pediatric Perforated Appendicitis
PHASE2
Active, not recruiting
200 participants
Started: Jul 25, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT03904862
Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery
PHASE1/PHASE2
Active, not recruiting
66 participants
Started: Jul 25, 2019 · Completed: Feb 21, 2030
3 conditions
4 sponsors
12 locations
NCT03836014
Study Comparing Continuous Versus Fixed Duration Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
PHASE3
Active, not recruiting
436 participants
Started: Jul 25, 2019 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT03799445
Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma
PHASE2
Active, not recruiting
37 participants
Started: Jul 25, 2019 · Completed: Jun 30, 2026
11 conditions
2 sponsors
1 location
NCT03857620
Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer
NA
Active, not recruiting
325 participants
Started: Jul 24, 2019 · Completed: Oct 31, 2025
4 conditions
2 sponsors
44 locations
NCT03679221
Motoric Cognitive Risk and Depression
N/A
Active, not recruiting
30,000 participants
Started: Jul 24, 2019 · Completed: Dec 1, 2025
3 conditions
1 sponsor
1 location
NCT04038983
Risk for Short-term Adverse Events in Older Users in the Emergency Department
N/A
Active, not recruiting
10,000 participants
Started: Jul 24, 2019 · Completed: Jan 30, 2025
3 conditions
1 sponsor
1 location
NCT03872778
[177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-NeoB Lesion Uptake
PHASE1/PHASE2
Active, not recruiting
51 participants
Started: Jul 24, 2019 · Completed: Dec 1, 2026
1 condition
1 sponsor
11 locations
NCT04082533
Intravenous (IV) Hydrocortisone for TKA (Total Knee Arthroplasty)
PHASE4
Active, not recruiting
132 participants
Started: Jul 24, 2019 · Completed: May 31, 2026
3 conditions
1 sponsor
1 location
Previous
1
More pages
306
307
308
309
310
311
312
More pages
431
Next